Nongenomic, endothelium-independent effects of estrogen on human coronary smooth muscle are mediated by type I (neuronal) NOS and PI3-kinase-Akt signaling
- 1 July 2007
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 293 (1) , H314-H321
- https://doi.org/10.1152/ajpheart.01342.2006
Abstract
Sex steroids exert profound and controversial effects on cardiovascular function. For example, estrogens have been reported to either ameliorate or exacerbate coronary heart disease. Although estrogen dilates coronary arteries from a variety of species, the molecular basis for this acute, nongenomic effect is unclear. Moreover, we know very little of how estrogen affects human coronary artery smooth muscle cells (HCASMC). The purpose of this study was to elucidate nongenomic estrogen signal transduction in HCASMC. We have used tissue (arterial tension studies), cellular (single-channel patch clamp, fluorescence), and molecular (protein expression) techniques to now identify novel targets of estrogen action in HCASMC: type I (neuronal) nitric oxide synthase (nNOS) and phosphatidylinositol 3-kinase (PI3-kinase)Akt. 17β-Estradiol (E2) increased NO-stimulated fluorescence in HCASMC, and cell-attached patch-clamp experiments revealed that stimulation of nNOS leads to increased activity of calcium-activated potassium (BKCa) channels in these cells. Furthermore, overexpression of nNOS protein in HCASMC greatly enhanced BKCa channel activity. Immunoblot studies demonstrated that E2 enhances Akt phosphorylation in HCASMC and that wortmannin, an inhibitor of PI3-kinase, attenuated E2-stimulated channel activity, NO production, Akt phosphorylation, and estrogen-stimulated coronary relaxation. These studies implicate the PI3-kinase/Akt signaling axis as an estrogen transduction component in vascular smooth muscle cells. We conclude, therefore, that estrogen opens BKCa channels in HCASMC by stimulating nNOS via a transduction sequence involving PI3-kinase and Akt. These findings now provide a molecular mechanism that can explain the clinical observation that estrogen enhances coronary blood flow in patients with diseased or damaged coronary arteries.Keywords
This publication has 40 references indexed in Scilit:
- Estrogen Replacement and Cardiomyocyte ProtectionTrends in Cardiovascular Medicine, 2006
- Estrogen Receptor α Mediates Acute Potassium Channel Stimulation in Human Coronary Artery Smooth Muscle CellsThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Estrogen-induced contraction of coronary arteries is mediated by superoxide generated in vascular smooth muscle.American Journal of Physiology-Heart and Circulatory Physiology, 2005
- 17β-Estradiol regulates nNOS and eNOS activity in the hippocampusNeuroReport, 2004
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Expression of nitric oxide synthase isoforms in pregnant human myometriumThe Journal of Physiology, 1999
- Regulators of sperm functionMolecular Human Reproduction, 1996
- Oestrogen relaxes human epicardial coronary arteries through non-endothelium-dependent mechanismsCoronary Artery Disease, 1995
- Endothelium independent relaxation of human coronary arteries by 17 -oestradiol in vitroCardiovascular Research, 1993
- Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery diseaseThe Lancet, 1993